2 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Hangzhou Institute of Innovative Medicine